Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
N/A
-77,208 Reduced 85.12%
13,501 $8,000
Q1 2022

May 16, 2022

SELL
N/A
-39,619 Reduced 30.4%
90,709 $120,000
Q4 2021

Feb 14, 2022

SELL
N/A
-169,488 Reduced 56.53%
130,328 $340,000
Q3 2021

Nov 15, 2021

BUY
N/A
92,273 Added 44.46%
299,816 $932,000
Q2 2021

Aug 16, 2021

BUY
N/A
207,543 New
207,543 $772,000
Q1 2021

May 17, 2021

SELL
N/A
-55,753 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
N/A
26,501 Added 90.6%
55,753 $187,000
Q3 2020

Nov 16, 2020

SELL
N/A
-130,215 Reduced 81.66%
29,252 $103,000
Q2 2020

Aug 14, 2020

BUY
N/A
61,025 Added 61.99%
159,467 $734,000
Q1 2020

May 14, 2020

BUY
N/A
98,442 New
98,442 $326,000
Q4 2019

Feb 14, 2020

SELL
N/A
-60,146 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
N/A
60,146 New
60,146 $250,000
Q2 2019

Aug 14, 2019

SELL
N/A
-121,979 Closed
0 $0
Q1 2019

May 14, 2019

SELL
N/A
-11,043 Reduced 8.3%
121,979 $1.16 Million
Q4 2018

Feb 14, 2019

BUY
N/A
133,022 New
133,022 $411,000

About PHASEBIO PHARMACEUTICALS INC C


  • Ticker PHASQ
More about PHASQ
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.